Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: finance – Page 131

You could drive past and never see the only farm in San Carlos, California. The tiny city of 30,000 that sits between San Francisco and Silicon Valley has all the charms of suburbia—sprawling office parks and single-story homes—but doesn’t seem a likely suspect for agriculture.

The farm, run by startup Iron Ox, is nestled between three stonemasons and a plumber in a nondescript office park building; there’s no greenhouse, no rows of freshly-tilled soil, or tractor parked outside. Only peeking in the large bay door reveals the building’s tenants: a few hundred plants and two brightly-colored robot farmers.

Iron Ox looks a lot like a tech company. One of its co-founder is an ex-Google engineer and it raised $1.5 million in pre-seed venture capital from Y Combinator, Pathbreaker, and Cherubic Ventures in April 2016. Instead of fake food, or plant-based meat meals, or even a food delivery service tethered to an app, Iron Ox is reinventing farming, raising real, not faux, food. Think hydroponically raised lettuce and basil, like what you’d get at an ordinary farmers market.

Read more

These are a tiny fraction of the examples of how our economy differs from the 20th century industrial economy. Similar changes are under way in the developing world, as labor gives way to robotics and basic goods become affordable and accessible to the planet’s billions. Given those changes, why would 20th century models of prices and rates and money supply work as they used to work?

We like to believe that there are “laws of economics” and past patterns to guide us, but, as Yellen indicated, there is now “considerable uncertainty.” It may feel safer to trust that past patterns will reassert themselves. But maybe policymakers should weigh more heavily the chance that the patterns have changed.

The Federal Reserve takes a 20th-century approach to managing a 21st-century economy.

Read more

Jim Mellon and Al Chalabi are back with another successful venture into the world of science investment. Following their acclaimed 2012 book “Cracking the code”, whose spotlight was on the life sciences industry, Juvenescence takes us on a compelling journey through the dawning market of longevity and rejuvenation biotechnology, which the authors predict will be the biggest “money fountain” to hit the financial world in the coming years.

Juvenescence is a visionary book, debunking the sometimes questionable past of longevity research and steering us towards a ‘brave new world’ in which advances in medicine are already leading to clinical trials whose aim is to extend human lifespan to unprecedented levels.

Mellon and Chalabi come across as eloquent devotees of cold, hard science, and for a book targeted primarily at investors, biologists and experts will be hard-pressed to find inaccuracies in the many heavily technical sections. The authors explain the science of aging in an engaging and accessible manner, bridging the gap between the lab and the public with ease and tact. They employ elegant metaphors to explain complex processes as well as some light-hearted ones, including the “Deadly Quintet”, which reads more like the title of a long-lost Tarantino film, or the “Actuarial Escape Velocity”, a reference to the controversial “Longevity Escape Velocity” promoted by Aubrey de Grey. Mellon and Chalabi use state-of-the-art research whenever possible, with recent, fresh-from-the-lab studies making up the majority of sources.

Read more

Only two years ago, when I launched my advocacy website Rejuvenaction, I didn’t think I would read a book like Juvenescence so soon; yet, the topic of rejuvenation biotechnologies has already become mainstream enough to lead investors of the calibre of Jim Mellon and Al Chalabi to devote a whole book to it.

As Juvenescence is a book aimed at potential new investors in rejuvenation biotechnologies, I expected it to be an extremely technical and detailed account of things I don’t understand, such as finance, markets, and funds. To my delight, this was not the case. Rather, the details Juvenescence dives into are primarily those of the emerging field of rejuvenation science (alas, still something whose details I don’t fully understand).

The book explains the paradigm shift that is currently taking place and changing the way science sees aging—no longer as an inevitable fact of life but rather as a disease to be eradicated like any other—and goes through a biology 101 crash course for the benefit of readers who might be not too well versed in the science of life.

Read more

In addition to Deloitte, the other remaining big-four accounting firms – including EY, KPMG and PwC – have introduced the technology-driven services in China to businesses ranging from banking, technology, and consumer services.

Mainland based accountants are embracing automation to lower office administration costs and enhance efficiency, moves which are opening the door to a wider embrace of artificial intelligence (AI).

Delixi Electric, a manufacturer of low-voltage electrical products, is banking on robotics to trim time needed for tax invoice issuance by 75 per cent. The Zhejiang province-based company needs to issue more than 5,000 value-added-tax invoices to more than 600 clients nationwide monthly.

A human needs 20 minutes to issue each invoice, which entails information collection, verification and recording. However, the same work can be done in five minutes by a robot, according to Deloitte, the robot supplier.

Continue reading “Robots finds a welcome reception among China’s finance and tax services” | >

Ariadna Font Llitjós of IBM Emerging Technology, Director of Emerging Technology Experiences at IBM Experiences, moderated the MIT Venture Capital + Innovation Conference at the MIT Sloan School of Management on June 2017. The main question of this panel was “What do Machine Learning and Artificial Intelligence mean for our future?”

Experts * S. Somasegar of Madrona Venture Group * Karl Iagnemma of NuTonomy, CEO of Nutonomy and Principal Research Scientist at MIT * Gareth Keane of Qualcomm Ventures * Saikat Dey of GuardHat, Co-Founder of GuardHat.

Read more